全文获取类型
收费全文 | 435374篇 |
免费 | 5529篇 |
国内免费 | 1228篇 |
专业分类
化学 | 233771篇 |
晶体学 | 6489篇 |
力学 | 18764篇 |
综合类 | 13篇 |
数学 | 49929篇 |
物理学 | 133165篇 |
出版年
2021年 | 3761篇 |
2020年 | 4185篇 |
2019年 | 4520篇 |
2018年 | 5853篇 |
2017年 | 5744篇 |
2016年 | 8832篇 |
2015年 | 5563篇 |
2014年 | 8542篇 |
2013年 | 20184篇 |
2012年 | 15648篇 |
2011年 | 19263篇 |
2010年 | 13498篇 |
2009年 | 13350篇 |
2008年 | 17647篇 |
2007年 | 17541篇 |
2006年 | 16252篇 |
2005年 | 14550篇 |
2004年 | 13525篇 |
2003年 | 11892篇 |
2002年 | 11728篇 |
2001年 | 13429篇 |
2000年 | 10085篇 |
1999年 | 7917篇 |
1998年 | 6569篇 |
1997年 | 6314篇 |
1996年 | 6082篇 |
1995年 | 5470篇 |
1994年 | 5392篇 |
1993年 | 5197篇 |
1992年 | 5828篇 |
1991年 | 5924篇 |
1990年 | 5664篇 |
1989年 | 5472篇 |
1988年 | 5493篇 |
1987年 | 5374篇 |
1986年 | 5091篇 |
1985年 | 6561篇 |
1984年 | 6694篇 |
1983年 | 5301篇 |
1982年 | 5387篇 |
1981年 | 5367篇 |
1980年 | 4955篇 |
1979年 | 5352篇 |
1978年 | 5491篇 |
1977年 | 5386篇 |
1976年 | 5328篇 |
1975年 | 4914篇 |
1974年 | 4885篇 |
1973年 | 4880篇 |
1972年 | 3455篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
93.
Eco‐friendly ionic liquid assisted capillary electrophoresis and α‐acid glycoprotein‐assisted liquid chromatography for simultaneous determination of anticancer drugs in human fluids
下载免费PDF全文
![点击此处可从《Biomedical chromatography : BMC》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Deia Abd El‐Hady Hassan M. Albishri Rajesh Rengarajan 《Biomedical chromatography : BMC》2015,29(6):925-934
In the current work, two eco‐friendly analytical methods based on capillary electrophoresis (CE) and reversed phase liquid chromatography (RPLC) were developed for simultaneous determination of the most commonly used anticancer drugs for Hodgkin's disease: methotrexate (MTX), vinblastine, chlorambucil and dacarbazine. A background electrolyte (BGE) of 12.5 mmol/L phosphate buffer at pH 7.4 and 0.1 µmol/L 1‐butyl‐3‐methyl imidazolium bromide (BMImBr) ionic liquid (IL) was used for CE measurements at 250 nm detection wavelength, 20 kV applied voltage and 25 °C. The rinsing protocol was significantly improved to reduce the adsorption of IL on the interior surface of capillary. Moreover, RPLC method was developed on α‐1‐acid glycoprotein (AGP) column. Mobile phase was 10 mmol/L phosphate buffer at pH 6.0 (100% v/v) and flow rate at 0.1 mL/min. As AGP is a chiral column, it was successfully separated l ‐MTX from its enantiomer impurity d ‐MTX. Good linearity of quantitative analysis was achieved with coefficients of determinations (r2) >0.995. The stability of drugs measurements was investigated with adequate recoveries up to 24 h storage time under ambient temperature. The limits of detection were <50 and 90 ng/mL by CE and RPLC, respectively. The using of short‐chain IL as an additive in BGE achieved 600‐fold sensitivity enhancement compared with conventional Capillary Zone Electrophoresis (CZE). Therefore, for the first time, the proposed methods were successfully applied to determine simultaneously the analytes in human plasma and urine samples at clinically relevant concentrations with fast and simple pretreatments. Developed IL‐assisted CE and RPLC methods were also applied to measure MTX levels in patients’ samples over time. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献
94.
95.
96.
97.
98.
99.
100.
Walter N. Harrington Christina M. Kackos Richard J. Webby 《Experimental & molecular medicine》2021,53(5):737
The influenza virus is a global threat to human health causing unpredictable yet recurring pandemics, the last four emerging over the course of a hundred years. As our knowledge of influenza virus evolution, distribution, and transmission has increased, paths to pandemic preparedness have become apparent. In the 1950s, the World Health Organization (WHO) established a global influenza surveillance network that is now composed of institutions in 122 member states. This and other surveillance networks monitor circulating influenza strains in humans and animal reservoirs and are primed to detect influenza strains with pandemic potential. Both the United States Centers for Disease Control and Prevention and the WHO have also developed pandemic risk assessment tools that evaluate specific aspects of emerging influenza strains to develop a systematic process of determining research and funding priorities according to the risk of emergence and potential impact. Here, we review the history of influenza pandemic preparedness and the current state of preparedness, and we propose additional measures for improvement. We also comment on the intersection between the influenza pandemic preparedness network and the current SARS-CoV-2 crisis. We must continually evaluate and revise our risk assessment and pandemic preparedness plans and incorporate new information gathered from research and global crises.Subject terms: Influenza virus, Infectious diseases 相似文献